COLTRINI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.387
EU - Europa 2.583
AS - Asia 978
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 4
Totale 6.973
Nazione #
US - Stati Uniti d'America 3.373
PL - Polonia 1.085
CN - Cina 473
UA - Ucraina 382
DE - Germania 375
IT - Italia 226
SG - Singapore 181
GB - Regno Unito 153
HK - Hong Kong 118
FI - Finlandia 110
IE - Irlanda 65
TR - Turchia 60
VN - Vietnam 54
RU - Federazione Russa 47
IN - India 42
ES - Italia 31
FR - Francia 29
CZ - Repubblica Ceca 23
ID - Indonesia 17
SE - Svezia 17
CA - Canada 13
BE - Belgio 12
NL - Olanda 9
IR - Iran 7
AU - Australia 6
EU - Europa 6
CH - Svizzera 5
PH - Filippine 5
KR - Corea 4
JP - Giappone 3
LK - Sri Lanka 3
PE - Perù 3
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
EG - Egitto 2
KG - Kirghizistan 2
LT - Lituania 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MG - Madagascar 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
TW - Taiwan 1
Totale 6.973
Città #
Warsaw 1.084
Fairfield 461
Woodbridge 348
Jacksonville 283
Ashburn 266
Ann Arbor 253
Houston 228
Cambridge 196
Chandler 173
Seattle 155
Singapore 149
Wilmington 148
Brescia 142
Princeton 122
Hong Kong 114
Nanjing 97
Beijing 93
Dearborn 88
Dublin 65
Helsinki 59
New York 59
Istanbul 55
Dong Ket 52
Lancaster 42
Nanchang 34
Des Moines 31
Los Angeles 29
Madrid 28
Jinan 25
Shanghai 24
Shenyang 23
Brno 22
Hebei 22
Milan 19
San Francisco 19
Tianjin 19
Washington 19
London 18
San Diego 18
Jakarta 16
Jiaxing 16
Changsha 15
Boardman 14
Brussels 12
Munich 12
San Mateo 12
Kunming 11
Falls Church 10
Haikou 9
Hangzhou 9
Nürnberg 9
Zhengzhou 9
Leawood 8
Taizhou 8
Verona 8
Ningbo 7
Toronto 7
Ardabil 6
Augusta 6
Dronten 6
Hefei 6
Kilburn 6
Lanzhou 6
Norwalk 6
Phoenix 6
Turin 6
Chicago 5
Monmouth Junction 5
Ottawa 5
Chiswick 4
Modena 4
Santa Clara 4
Baliuag 3
Colombo 3
Guangzhou 3
Kocaeli 3
Lima 3
Nashville 3
New Delhi 3
Orange 3
Tokyo 3
Yellow Springs 3
Zurich 3
Amsterdam 2
Auburn Hills 2
Barcelona 2
Bishkek 2
Bratislava 2
Buenos Aires 2
Camerino 2
Canberra 2
Catania 2
Cerreto Guidi 2
Charlottesville 2
Fort Lauderdale 2
Fuzhou 2
Gunzenhausen 2
Highland Park 2
Indiana 2
Ivry-sur-seine 2
Totale 5.422
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 270
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 234
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 233
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 232
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 230
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 225
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 219
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 212
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 193
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 164
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 157
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 153
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 150
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 147
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 142
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 132
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 131
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 130
P2y1 and P2y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells. 128
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 127
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 126
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 124
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 120
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 118
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 115
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 113
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 113
Beta-Galactosylceramidase deficiency: neurovascular implications 113
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 112
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 109
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 106
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 103
Cardiac microvascular endothelial cells express a functional Ca2+ -sensing receptor 102
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 100
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. 89
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 88
Role of inflammation in FGF2-driven angiogenesis 87
The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells. 86
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 86
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 85
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 84
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 72
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 71
Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. 70
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 70
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 68
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 67
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 61
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 59
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 58
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 58
upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumor cell lines derived from BK virus/tat-transgenic mice 57
The interaction of basic fibroblast growth factor (bFGF) with heparan sulfate proteoglycans: biochemical bases and biological implications 57
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 55
Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors 53
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 53
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. 52
Impact of fibroblast growth factor-2 (FGF2) on tumor growth and vascularization: Establishing a "FGF2-dependent" tumor model 51
Natural killer cell impairment in ovarian clear cell carcinoma 51
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 51
Interaction of HIV-1 tat protein with heparin:role of the backbone structure, sulfation, and size 48
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 43
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 41
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 36
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 19
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 13
Totale 7.122
Categoria #
all - tutte 30.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.317 0 0 0 0 118 224 220 202 143 203 108 99
2020/20211.204 41 125 57 147 71 121 37 132 150 100 140 83
2021/2022626 41 115 10 16 11 45 43 31 25 80 60 149
2022/2023534 98 18 30 34 48 117 7 47 49 4 50 32
2023/2024670 46 42 79 24 29 92 33 26 126 47 16 110
2024/2025323 9 14 6 187 107 0 0 0 0 0 0 0
Totale 7.122